Danish pharmaceutical giant Novo Nordisk is gearing up to introduce its blockbuster anti-diabetes and weight-loss drug Wegovy (semaglutide) in India. In a strategic move to gain an advantage over Eli Lilly’s newly launched Mounjaro (tirzepatide), Novo Nordisk has presented data showcasing Wegovy’s cardiovascular benefits in Indian patients, according to recent regulatory filings.
IndiGo's board chairman Vikram Singh Mehta has issued a statement refuting claims that the airline intentionally orchestrated recent flight cancellations to pressure the government into relaxing pilot rest-hour regulations. The chairman emphasized...
Meesho shares delivered an impressive market performance on their Dalal Street debut, opening at a significant premium following robust investor demand during the IPO subscription period. The company listed at Rs 162.05...
As IndiGo’s nationwide operations remained in turmoil for the fourth consecutive day on Friday, around 30 flights from Goa’s Dabolim airport were cancelled in the morning, disrupting services to key cities such...
Industry Insights Magazine delivers expert analysis, trends, and startup stories across sectors like Finance, Healthcare, Manufacturing, and Real Estate. With curated interviews, case studies, and reports, we empower professionals and entrepreneurs with actionable insights, helping them navigate change, discover opportunities, and lead confidently in today’s dynamic business landscape.
Discussion about this post